TR200101864T2 - Tilidinmesilat etkin maddeli, kontrollü açığa bırakan farmasötik bileşimler. - Google Patents

Tilidinmesilat etkin maddeli, kontrollü açığa bırakan farmasötik bileşimler.

Info

Publication number
TR200101864T2
TR200101864T2 TR2001/01864T TR200101864T TR200101864T2 TR 200101864 T2 TR200101864 T2 TR 200101864T2 TR 2001/01864 T TR2001/01864 T TR 2001/01864T TR 200101864 T TR200101864 T TR 200101864T TR 200101864 T2 TR200101864 T2 TR 200101864T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
active release
tilidine mesylate
mesylate
tilidine
Prior art date
Application number
TR2001/01864T
Other languages
English (en)
Inventor
Hirsch Richard
Wesseling Martin
Str�Ngmann Thomas
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of TR200101864T2 publication Critical patent/TR200101864T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bulus etkin madde olarak tilidinmesilat içeren kontrollü açiga birakan, kati, oral yoldan takdim edilen, farmasötik bir bilesim ile ilgilidir.
TR2001/01864T 1998-12-23 1999-12-23 Tilidinmesilat etkin maddeli, kontrollü açığa bırakan farmasötik bileşimler. TR200101864T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19859636A DE19859636A1 (de) 1998-12-23 1998-12-23 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff

Publications (1)

Publication Number Publication Date
TR200101864T2 true TR200101864T2 (tr) 2002-01-21

Family

ID=7892368

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01864T TR200101864T2 (tr) 1998-12-23 1999-12-23 Tilidinmesilat etkin maddeli, kontrollü açığa bırakan farmasötik bileşimler.

Country Status (22)

Country Link
US (1) US6579536B1 (tr)
EP (1) EP1140031B1 (tr)
JP (1) JP2002533381A (tr)
AT (1) ATE252377T1 (tr)
AU (1) AU770293B2 (tr)
BR (1) BR9916575A (tr)
CA (1) CA2355891A1 (tr)
CZ (1) CZ301628B6 (tr)
DE (2) DE19859636A1 (tr)
DK (1) DK1140031T3 (tr)
ES (1) ES2207334T3 (tr)
HK (1) HK1039273A1 (tr)
HU (1) HUP0104647A3 (tr)
MX (1) MXPA01006493A (tr)
NO (1) NO320022B1 (tr)
NZ (1) NZ512079A (tr)
PL (1) PL199024B1 (tr)
PT (1) PT1140031E (tr)
SK (1) SK284901B6 (tr)
TR (1) TR200101864T2 (tr)
WO (1) WO2000038656A1 (tr)
ZA (1) ZA200105040B (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
HU1500214D0 (hu) 1997-12-22 2002-03-28 Euro Celtique Sa Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
PL357158A1 (en) * 2000-02-08 2004-07-12 Euro-Celtique, S.A. Controlled-release compositions containing opioid agonist and antagonist
OA12215A (en) 2000-02-08 2006-05-09 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations.
ES2361148T3 (es) 2001-05-11 2011-06-14 Endo Pharmaceuticals Inc. Forma de dosificación de opioides de liberación controlada resistente al abuso.
EP2425823A1 (en) 2002-04-05 2012-03-07 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
JP2008507508A (ja) * 2004-07-22 2008-03-13 株式會社アモーレパシフィック トピラメート徐放性製剤及びその製造方法
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
EP2168945A1 (en) * 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
MX347106B (es) 2009-03-10 2017-04-12 Euro-Celtique S A * Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
CN105517551A (zh) 2013-07-23 2016-04-20 欧洲凯尔特公司 用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合
RU2017106028A (ru) 2014-09-19 2018-10-22 Дзе Проктер Энд Гэмбл Компани Лекарственная форма фенилэфрина с пульсирующим высвобождением
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71847A1 (tr) * 1975-02-14 1977-01-05
MX9306607A (es) * 1992-10-26 1994-04-29 Goedecke Ag Dindihidrogeno-otorfosfato de tilidina, procedimiento para su obtencion y las preparaciones farmaceuticas que lo contienen.
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
PT1073625E (pt) 1998-04-28 2003-11-28 Hexal Ag Mesilato de tilidina processos para a sua preparacao e sua composicao farmaceutica

Also Published As

Publication number Publication date
NO20013060L (no) 2001-06-20
EP1140031B1 (de) 2003-10-22
AU770293B2 (en) 2004-02-19
PL199024B1 (pl) 2008-08-29
US6579536B1 (en) 2003-06-17
HK1039273A1 (en) 2002-04-19
ZA200105040B (en) 2002-05-22
SK284901B6 (sk) 2006-02-02
MXPA01006493A (es) 2002-06-04
PL348419A1 (en) 2002-05-20
AU2286200A (en) 2000-07-31
JP2002533381A (ja) 2002-10-08
PT1140031E (pt) 2004-03-31
EP1140031A1 (de) 2001-10-10
DK1140031T3 (da) 2003-12-01
DE19859636A1 (de) 2000-06-29
DE59907481D1 (de) 2003-11-27
HUP0104647A3 (en) 2003-12-29
NO320022B1 (no) 2005-10-10
HUP0104647A2 (hu) 2002-03-28
ATE252377T1 (de) 2003-11-15
SK8922001A3 (en) 2001-12-03
ES2207334T3 (es) 2004-05-16
BR9916575A (pt) 2001-09-18
CZ301628B6 (cs) 2010-05-05
NZ512079A (en) 2003-08-29
WO2000038656A1 (de) 2000-07-06
NO20013060D0 (no) 2001-06-20
CZ20012167A3 (cs) 2001-11-14
CA2355891A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
TR200101864T2 (tr) Tilidinmesilat etkin maddeli, kontrollü açığa bırakan farmasötik bileşimler.
TR200707263T2 (tr) Uzun sürede dışarıya yayılan eritromisin türevi formülleri.
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
DK1157037T3 (da) GCSF-konjugater
FR2795324B1 (fr) Compositions pharmaceutiques stabilisees
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
ZA200007715B (en) Stable extended release oral dosage composition.
BR9916835A (pt) Composição de galantamina de liberação controlada
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
DK1156777T3 (da) Præparat til oral administration til inhibering af dårlig ånde
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
HN1999000066A (es) Formulaciones farmaceuticas
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
NO20026123L (no) Farmasöytiske sammensetninger
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
FR2802423B1 (fr) Compositions pharmaceutiques
BRPI0408848A (pt) formulações orais de cladribine
HN1998000045A (es) Composiciones farmaceuticas
TR200102566T2 (tr) Kontrollü salınan betahistin bileşimleri.
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.